Cited by 1,947Receptor Mechanisms and SignalingIon channel regulation and functionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 3 of the 7 references it cites were found in a registry or an index, and 4 are not checked yet.

Guide to Receptors and Channels (GRAC), 5th edition

Open access

Alexander, SPH, Mathie, A, Peters, JA·2011·British Journal of Pharmacology

DOI 10.1111/j.1476-5381.2011.01649_1.xPMC PMC3315626

Open this paper in CoChat — free account Open PDF

Abstract

The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01649_1.x

Cites

3 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 313
Guide to Receptors and Channels (GRAC), 4th edition
Alexander, S. P. H., & Peters, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00499.x · Cited by 249
Self-citation
The oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 103
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
The VPAC 2 agonist peptide histidine isoleucine (PHI) up‐regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1 G93A ) by inhibiting caspase‐3 mediated inactivation of GLT‐1a
Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J., & Hermans, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182337 · Cited by 14

Show all 2 references

Sorted by citations

Items 201–300 of 1,000

Small‐interfering RNA s ( siRNA s) as a promising tool for ocular therapy
Guzmán‐Aránguez, A., Loma, P., & Pintor, J. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12330 · Cited by 121
Expression and function of the K+channelKCNQgenes in human arteries
Ng, F. L., Davis, A. J., Jepps, T. A., Harhun, M. I., Yeung, S. Y. M., Wan, A. C. T., Reddy, M., Melville, D. M., Nardi, A. E., Khong, T. K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01027.x · Cited by 117
Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines
Dahan, L., Sadok, A., Formento, J., Seitz, J. F., & Kovacic, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00341.x · Cited by 117
Rational design of dualsteric GPCR ligands: quests and promise
Mohr, K., Tränkle, C., Kostenis, E., Barocelli, E., Amici, M. D., & Holzgrabe, U. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00601.x · Cited by 117
The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice
Booker, L., Kinsey, S. G., Abdullah, R. A., Blankman, J. L., Long, J. Z., Ezzili, C., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01445.x · Cited by 116
Involvement of α2‐ and β2‐adrenoceptors on breast cancer cell proliferation and tumour growth regulation
Piñero, C. P., Bruzzone, A., Sarappa, M. G., Castillo, L. F., & Lüthy, I. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01791.x · Cited by 116
Paraptosis: a unique cell death mode for targeting cancer
Hanson, S., Dharan, A., Jinsha, P. V., Pal, S., Nair, B. G., Kar, R., & Mishra, N. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1159409 · Cited by 124
Naringin improves bone properties in ovariectomized mice and exerts oestrogen‐like activities in rat osteoblast‐like (UMR‐106) cells
Pang, W., Wang, X. F., Mok, S., Lai, W., Chow, D. H. K., Leung, P., Yao, X., & Wong, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00664.x · Cited by 118
Subtype‐selective targeting of voltage‐gated sodium channels
England, S., & de Groot, M. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00437.x · Cited by 118
Quercetin induces insulin secretion by direct activation of L‐type calcium channels in pancreatic beta cells
Bardy, G., Virsolvy, A., Quignard, J., Ravier, M., Bertrand, G., Dalle, S., Cros, G., Magous, R., Richard, S., & Oiry, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12194 · Cited by 110
Anti‐platelet therapy: ADP receptor antagonists
Wijeyeratne, Y. D., & Heptinstall, S. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03999.x · Cited by 120
IL‐1β induces expression of matrix metalloproteinase‐9 and cell migration via a c‐Src‐dependent, growth factor receptor transactivation in A549 cells
Cheng, C., Kuo, C., Lin, C., Hsieh, H., & Yang, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00858.x · Cited by 119
A role for nitroxyl (HNO) as an endothelium‐derived relaxing and hyperpolarizing factor in resistance arteries
Andrews, K. L., Irvine, J. C., Tare, M., Apostolopoulos, J., Favaloro, J. L., Triggle, C. R., & Kemp‐Harper, B. K. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00150.x · Cited by 114
Extrasensory perception: Odorant and taste receptors beyond the nose and mouth
Foster, S. R., Roura, E., & Thomas, W. G. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.004 · Cited by 117
G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications
Arterburn, J. B., & Prossnitz, E. R. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031122-121944 · Cited by 114
A new cannabinoid CB2 receptor agonist HU‐910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Horváth, B., Magid, L., Mukhopadhyay, P., Bátkai, S., Rajesh, M., Park, O., Tanchian, G., Gao, R. Y., Goodfellow, C. E., Glass, M., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01381.x · Cited by 112
Real‐time characterization of cannabinoid receptor 1 ( CB 1) allosteric modulators reveals novel mechanism of action
Cawston, E. E., Redmond, W. J., Breen, C. M., Grimsey, N. L., Connor, M. A., & Glass, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12329 · Cited by 110
Expression, assembly and function of novel C‐terminal truncated variants of the mouse P2X7 receptor: re‐evaluation of P2X7 knockouts
Masin, M., Young, C., Lim, K., Barnes, S. J., Xu, X., Marschall, V., Brutkowski, W., Mooney, E. R., Górecki, D. C., & Murrell‐Lagnado, R. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01624.x · Cited by 112
Selective Inhibition of KCC2 Leads to Hyperexcitability and Epileptiform Discharges in Hippocampal Slices and In Vivo
Sivakumaran, S., Cardarelli, R. A., Maguire, J. L., Kelley, M. R., Silayeva, L., Morrow, D., Mukherjee, J. T., Moore, Y. E., Mather, R. J., Duggan, M. E., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5205-14.2015 · Cited by 115
Position paper: The membrane estrogen receptor GPER – Clues and questions
Barton, M. (2012) · Steroids · doi:10.1016/j.steroids.2012.04.001 · Cited by 112
IUPHAR-DB: updated database content and new features
Sharman, J. L., Benson, H. E., Pawson, A. J., Lukito, V., Mpamhanga, C. P., Bombail, V., Davenport, A. P., Peters, J. A., Spedding, M., Harmar, A. J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks960 · Cited by 112
Self-citation
Endocannabinoids and Traumatic Brain Injury
Mechoulam, R., & Shohami, E. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8008-6 · Cited by 111
Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products
Liang, C., Ren, Y., Tan, H., He, Z., Jiang, Q., Wu, J., Zhen, Y., Fan, M., & Wu, Z. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00450.x · Cited by 111
Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K / Akt signalling
Sun, B., Xiao, J., Sun, X., & Wu, Y. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12063 · Cited by 111
Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first‐in‐human study
Brossard, P., Derendorf, H., Xu, J., Maatouk, H., Halabi, A., & Dingemanse, J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12129 · Cited by 111
The GPCR OGR1 (GPR68) mediates diverse signalling and contraction of airway smooth muscle in response to small reductions in extracellular pH
Saxena, H., Deshpande, D. A., Tiegs, B. C., Yan, H., Battafarano, R., Burrows, W., Damera, G., Panettieri, R., DuBose, T., An, S. S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01807.x · Cited by 111
Molecular basis for amino acid sensing by family C G‐protein‐coupled receptors
Wellendorph, P., & Bräuner‐Osborne, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00078.x · Cited by 111
Curcumin inhibits gene expression of receptor for advanced glycation end‐products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress
Lin, J., Tang, Y., Kang, Q., Feng, Y., & Chen, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01910.x · Cited by 111
Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects
Ali, Z., Laurijssens, B. E., Ostenfeld, T., McHugh, S. M., Stylianou, A., Scott‐Stevens, P., Hosking, L. K., Dewit, O., Richardson, J. C., & Chen, C. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04320.x · Cited by 111
Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan‐induced knee joint synovitis in the rat
Ekundi-Valentim, E., Santos, K., Camargo, E. A., Denadai‐Souza, A., Teixeira, S. A., Zanoni, C., Grant, A. D., Wallace, J., Muscará, M. N., & Costa, S. K. P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00640.x · Cited by 111
Synaptic Neurotransmitter-Gated ReceptorsPreprint
Smart, T. G., & Paoletti, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009662 · Cited by 110
In pursuit of small molecule chemistry for calcium‐permeable non‐selective TRPC channels – mirage or pot of gold?
Bon, R. S., & Beech, D. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12274 · Cited by 110
Open questions in current models of antidepressant action
Tanti, A., & Belzung, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00585.x · Cited by 115
Norepinephrine exerts an inotropic effect during the early phase of human septic shock
Hamzaoui, O., Jozwiak, M., Geffriaud, T., Sztrymf, B., Prat, D., Jacobs, F., Monnet, X., Trouiller, P., Richard, C., & Teboul, J. (2017) · British Journal of Anaesthesia · doi:10.1016/j.bja.2017.11.065 · Cited by 110
Blockade of adenosine A2B receptors ameliorates murine colitis
Kolachala, V. L., Ruble, B. K., Vijay–Kumar, M., Wang, L., Mwangi, S. M., Figler, H., Figler, R. A., Srinivasan, S., Gewirtz, A. T., Linden, J. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.227 · Cited by 110
Levetiracetam inhibits glutamate transmission through presynaptic P/Q‐type calcium channels on the granule cells of the dentate gyrus
Lee, C.-Y., Chen, C., & Liou, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00463.x · Cited by 109
Differences in the expression of endogenous efflux transporters inMDR1‐transfected versus wildtype cell lines affect P‐glycoprotein mediated drug transport
Kuteykin‐Teplyakov, K. B., Luna‐Tortós, C., Ambroziak, K., & Löscher, W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00801.x · Cited by 110
Bath salts components mephedrone and methylenedioxypyrovalerone ( MDPV ) act synergistically at the human dopamine transporter
Cameron, K. N., Kolanoś, R., Solis, E., Glennon, R. A., & DeFelice, L. J. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12061 · Cited by 108
The case for peripheral CB1receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
Kunos, G., & Tam, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01352.x · Cited by 113
Molecular Mechanisms of Gonadotropin-Releasing Hormone Signaling: Integrating Cyclic Nucleotides into the Network
Perrett, R. M., & McArdle, C. A. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00180 · Cited by 107
Myocardial oxidative stress contributes to transgenic β2‐adrenoceptor activation‐induced cardiomyopathy and heart failure
Xu, Q., Dalic, A., Lu, F. Y., Kiriazis, H., Ritchie, R. H., Sim, K. S., Gao, X., Drummond, G. R., Sarwar, M., Zhang, Y., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01043.x · Cited by 108
Double‐transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations
König, J., Zolk, O., Singer, K., Hoffmann, C., & Fromm, M. F. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01052.x · Cited by 108
RETRACTED: Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation
Collino, M., Aragno, M., Castiglia, S., Miglio, G., Tomasinelli, C. E., Boccuzzi, G., Thiemermann, C., & Fantozzi, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00671.x · Cited by 107
Retracted
Drug‐ and cue‐induced reinstatement of cannabinoid‐seeking behaviour in male and female rats: influence of ovarian hormones
Fattore, L., Spano, M. S., Altea, S., Fadda, P., & Fratta, W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00734.x · Cited by 107
A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
Myöhänen, T. T., Hannula, M. J., Elzen, R. V., Gérard, M., der Veken, P. V., Garcia-Horsman, A., Baekelandt, V., Männistö, P. T., & Lambeir, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01846.x · Cited by 109
A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory
Smith, J. W., Gastambide, F., Gilmour, G., Dix, S. L., Foss, J., Lloyd, K. G., Malik, N. K., & Tricklebank, M. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2277-5 · Cited by 109
Epigenetic control of skin differentiation genes by phytocannabinoids
Pucci, M., Rapino, C., Francesco, A. D., Dainese, E., D’Addario, C., & Maccarrone, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12309 · Cited by 106
Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial KATPchannel
Grossini, E., Molinari, C. G., Caimmi, P. P., Uberti, F., & Vacca, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00024.x · Cited by 106
Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice
Huang, C., Lo, C., Chiu, C., & Shyur, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00581.x · Cited by 107
Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA‐1
Shan, H., Li, X., Pan, Z., Li, Z., Cai, B., Zhang, Y., Xu, C., Chu, W., Qiao, G., Li, B., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00377.x · Cited by 104
Cilostazol is anti‐inflammatory in BV2 microglial cells by inactivating nuclear factor‐kappaB and inhibiting mitogen‐activated protein kinases
Jung, W., Lee, D., Park, C., Choi, Y. H., Choi, I., Park, S., Seo, S., Lee, S., Yea, S. S., Ahn, S., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00615.x · Cited by 104
Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
Liu, J., Tsai, H.-J., Hwang, S. H., Jones, P. D., Morisseau, C. H. P., & Hammock, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00009.x · Cited by 104
International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function
Vaudry, H., Leprince, J., Chatenet, D., Fournier, A., Lambert, D. G., Mével, J. L., Ohlstein, E. H., Schwertani, A. G., Tostivint, H., & Vaudry, D. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009480 · Cited by 104
Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development
Salvi, V., Karnad, D. R., Panicker, G. K., & Kothari, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00427.x · Cited by 102
Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron–glia signaling
Fields, R. D. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.02.009 · Cited by 103
CK2—An Emerging Target for Neurological and Psychiatric Disorders
Castelló, J., Ragnauth, A. K., Friedman, E., & Rebholz, H. (2017) · Pharmaceuticals · doi:10.3390/ph10010007 · Cited by 104
Protective effect of hydrogen sulphide against 6‐OHDA‐induced cell injury in SH‐SY5Y cells involves PKC/PI3K/Akt pathway
Tiong, C. X., Lu, M., & Bian, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00887.x · Cited by 103
Possible alterations in GABAAreceptor signaling that underlie benzodiazepine‐resistant seizures
Deeb, T. Z., Maguire, J. L., & Moss, S. J. (2012) · Epilepsia · doi:10.1111/epi.12037 · Cited by 100
Augmentation of cognitive function by NS9283, a stoichiometry‐dependent positive allosteric modulator of α2‐ and α4‐containing nicotinic acetylcholine receptors
Timmermann, D. B., Sandager‐Nielsen, K., Dyhring, T., Smith, M., Jacobsen, A., Nielsen, E., Grunnet, M., Christensen, J., Peters, D., Kohlhaas, K. L., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01989.x · Cited by 103
The rush to adrenaline: drugs in sport acting on the β‐adrenergic system
Davis, E. A., Loiacono, R. E., & Summers, R. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.164 · Cited by 103
Spinal glial TLR4‐mediated nociception and production of prostaglandin E 2 and TNF
Saito, O., Svensson, C. I., Buczynski, M. W., Wegner, K., Hua, X., Codeluppi, S., Schaloske, R. H., Deems, R. A., Dennis, E. A., & Yaksh, T. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00811.x · Cited by 102
Neuropeptides and Neuropeptide Receptors: Drug Targets, and Peptide and Non‐Peptide Ligands: a Tribute to Prof.Dieter Seebach
Hoyer, D., & Bartfai, T. (2012) · Chemistry & Biodiversity · doi:10.1002/cbdv.201200288 · Cited by 102
The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin
Broad, J., & Sanger, G. J. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12077 · Cited by 102
Potent mechanism‐based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates
Filppula, A. M., Laitila, J., Neuvonen, P. J., & Backman, J. T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01732.x · Cited by 102
Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes
Bailey, R., Walker, C. S., Ferner, A. H., Loomes, K., Prijic, G., Halim, A., Whiting, L., Phillips, A., & Hay, D. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01717.x · Cited by 102
Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors
Nörenberg, W., Sobottka, H., Hempel, C., Plötz, T., Fischer, W., Schmalzing, G., & Schaefer, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01987.x · Cited by 102
Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein
Zhou, W., Zhang, X., Cheng, C., Wang, F., Wang, X., Liang, Y.-J., To, K. K. W., Wang, Z., Huang, H., & Fu, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01849.x · Cited by 100
A role for transient receptor potential vanilloid 4 in tonicity‐induced neurogenic inflammation
Vergnolle, N., Cénac, N., Altier, C., Cellars, L., Chapman, K., Zamponi, G. W., Materazzi, S., Nassini, R., Liedtke, W., Cattaruzza, F., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00590.x · Cited by 101
Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain
Dohi, T., Morita, K., Kitayama, T., Motoyama, N., & Morioka, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.018 · Cited by 100
Pharmacology of the short QT syndrome N588K‐hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs
McPate, M. J., Duncan, R. S., Hancox, J. C., & Witchel, H. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.325 · Cited by 101
Role of TRP Channels in Pain Sensation
Chung, M., Jung, S. J., & Oh, S. B. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_33 · Cited by 98
5‐HT6receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms
Woods, S., Clarke, N., Layfield, R., & Fone, K. C. F. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02022.x · Cited by 100
The phospholipase C inhibitor U‐73122 inhibits Ca2+release from the intracellular sarcoplasmic reticulum Ca2+store by inhibiting Ca2+pumps in smooth muscle
MacMillan, D., & McCarron, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00771.x · Cited by 104
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease
Hadoke, P. W. F., Iqbal, J., & Walker, B. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00047.x · Cited by 102
Novel ocular antihypertensive compounds in clinical trials
Chen, J., Runyan, & Robinson (2011) · Clinical ophthalmology · doi:10.2147/opth.s15971 · Cited by 99
Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801
Wu, X., Qian, Z., Zhu, L., Du, F., Yung, W., Gong, Q., & Ke, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01337.x · Cited by 99
Novel and Conventional Receptors for Ghrelin, Desacyl-Ghrelin, and Pharmacologically Related Compounds
Callaghan, B. P., & Furness, J. B. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008433 · Cited by 97
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
Giandalia, A., Giuffrida, A. E., Gembillo, G., Cucinotta, D., Squadrito, G., Santoro, D., & Russo, G. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115808 · Cited by 109
Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine
Moore, E. L., & Salvatore, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01633.x · Cited by 98
Statins suppress interleukin‐6‐induced monocyte chemo‐attractant protein‐1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells
Jougasaki, M., Ichiki, T., Takenoshita, Y., & Setoguchi, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00612.x · Cited by 99
Reduction of body weight, liver steatosis and expression of stearoyl‐CoA desaturase 1 by the isoflavone daidzein in diet‐induced obesity
Crespillo, A., Alonso, M., Vida, M., Pavón, F. J., Serrano, A., Rivera, P., Romero‐Zerbo, S., Fernández‐Llebrez, P., Martı́nez, A., Perez‐Valero, V., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01477.x · Cited by 97
N‐Acyl amino acids and N‐acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets
Connor, M. A., Vaughan, C. W., & Vandenberg, R. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00862.x · Cited by 97
A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain
Andó, R., Méhész, B., Gyires, K., Illés, P., & Sperlágh, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00596.x · Cited by 96
New insights into the molecular mechanisms of general anaesthetics
Chau, P.-L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00891.x · Cited by 100
Allosteric ligands for G protein-coupled receptors: A novel strategy with attractive therapeutic opportunities
Amici, M. D., Dallanoce, C., Holzgrabe, U., Tränkle, C., & Mohr, K. (2009) · Medicinal Research Reviews · doi:10.1002/med.20166 · Cited by 97
Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
Malinowska, B., Baranowska‐Kuczko, M., & Schlicker, E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01747.x · Cited by 100
Pharmacological characterization of LPS and opioid interactions at the toll‐like receptor 4
Stevens, C., Aravind, S., Das, S., & Davis, R. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12028 · Cited by 96
IL ‐33/ ST 2 signalling contributes to carrageenin‐induced innate inflammation and inflammatory pain: role of cytokines, endothelin‐1 and prostaglandin E 2
Zarpelon, A., Cunha, T. M., Alves‐Filho, J., Pinto, L. G., Ferreira, S., McInnes, I. B., Xu, D., Liew, F. Y., Cunha, F. Q., & Verri, W. A., Jr. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12110 · Cited by 99
The chemokine receptor CCR5 in the central nervous system
Sorce, S., Myburgh, R., & Krause, K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.003 · Cited by 107
Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, α‐ and β‐amyrin, in a mouse model of colitis
Vitor, C. B., Figueiredo, C. P., Hara, D., Bento, A., Mazzuco, T. L., & Calixto, J. Β. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00271.x · Cited by 96
Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells
Wareham, K., Vial, C., Wykes, R. C., Bradding, P. H., & Seward, E. P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00287.x · Cited by 96
Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediator
Zhang, X., Maor, Y., Jf, W., Kunos, G., & Groopman, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00841.x · Cited by 99
Low threshold T ‐type calcium channels as targets for novel epilepsy treatments
Powell, K. L., Cain, S. M., Snutch, T. P., & O'Brien, T. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12205 · Cited by 98
Mechanism of action of the insecticides, lindane and fipronil, on glycine receptor chloride channels
Islam, R., & Lynch, J. W. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01722.x · Cited by 99
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S
Mitchell, J., Maguire, J. J., & Davenport, A. P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00252.x · Cited by 94
N ‐acyl amines of docosahexaenoic acid and other n –3 polyunsatured fatty acids – from fishy endocannabinoids to potential leads
Meijerink, J., Balvers, M. G. J., & Witkamp, R. F. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12030 · Cited by 94
Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands
Baker, J. G., Middleton, R. J., Adams, L. A., May, L. T., Briddon, S. J., Kellam, B., & Hill, S. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00488.x · Cited by 94
The role of the paracrine/autocrine mediator endothelin‐1 in regulation of cardiac contractility and growth
Drawnel, F., Archer, C. R., & Roderick, H. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02195.x · Cited by 96
Acute Alcohol Action and Desensitization of Ligand-Gated Ion Channels
Dopico, A. M., & Lovinger, D. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000430 · Cited by 94
Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y
Painsipp, E., Herzog, H., Sperk, G., & Holzer, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01326.x · Cited by 93

Authors: Alexander, S., Mathie, A., & Peters, J.
Affiliations: University of Nottingham (GB)
Medway School of Pharmacy (GB)
University of Dundee (GB)
ORCID: Mathie, A
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2011-11
Volume: 164
Issue: s1
Pages: S1-324
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1111/j.1476-5381.2011.01649_1.x
PMC: PMC3315626
OpenAlex: W2069380892
Cited by: 1,947
References: 2
Citations by year: 2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
FWCI: 109.61
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: British Journal of Pharmacology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (submittedVersion)
Kent Academic Repository (University of Kent) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
MeSH terms: Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guide to Receptors and Channels (GRAC), 5th edition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks